Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Trepel

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Nature Communications|March 29, 2022
Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumorsFotis Nikolos, Kazukuni Hayashi, Xen Ping Hoi, et al.
Molecular Cancer Therapeutics|June 5, 2021
Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 ProfilingDeborah R Surman, Yuan Xu, Min-Jung Lee, et al.
Molecular and Cellular Biology|May 28, 2009
Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen speciesSunil Sudarshan, Carole Sourbier, Hye-Sik Kong, et al.
Cancer Research|May 4, 2023
CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic ExplorationsWilliam C Reinhold, Kelli Wilson, Fathi Elloumi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 21, 2011
Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomasShivaani Kummar, Martin E Gutierrez, Alice Chen, et al.
Cancer Cell|September 13, 2011
The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levelsWing-Hang Tong, Carole Sourbier, Gennady Kovtunovych, et al.
Hepatology (Baltimore, Md.)|June 11, 2015
Alternative splicing of the cell fate determinant Numb in hepatocellular carcinomaYinying Lu, Wanping Xu, Junfang Ji, et al.
Case Reports in Oncology|May 18, 2017
RRx-001 Priming of PD-1 Inhibition in the Treatment of Small Cell Carcinoma of the Vagina: A Rare Gynecological TumorChristina Brzezniak, Bryan Oronsky, Jane Trepel, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2013
Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysisSoichiro Yoshida, Shinji Tsutsumi, Guillaume Muhlebach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2017
Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular CarcinomaAustin G Duffy, Chi Ma, Susanna V Ulahannan, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Nature Communications|March 29, 2022
Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumorsFotis Nikolos, Kazukuni Hayashi, Xen Ping Hoi, et al.
Molecular Cancer Therapeutics|June 5, 2021
Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 ProfilingDeborah R Surman, Yuan Xu, Min-Jung Lee, et al.
Molecular and Cellular Biology|May 28, 2009
Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen speciesSunil Sudarshan, Carole Sourbier, Hye-Sik Kong, et al.
Cancer Research|May 4, 2023
CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic ExplorationsWilliam C Reinhold, Kelli Wilson, Fathi Elloumi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 21, 2011
Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomasShivaani Kummar, Martin E Gutierrez, Alice Chen, et al.
Cancer Cell|September 13, 2011
The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levelsWing-Hang Tong, Carole Sourbier, Gennady Kovtunovych, et al.
Hepatology (Baltimore, Md.)|June 11, 2015
Alternative splicing of the cell fate determinant Numb in hepatocellular carcinomaYinying Lu, Wanping Xu, Junfang Ji, et al.
Case Reports in Oncology|May 18, 2017
RRx-001 Priming of PD-1 Inhibition in the Treatment of Small Cell Carcinoma of the Vagina: A Rare Gynecological TumorChristina Brzezniak, Bryan Oronsky, Jane Trepel, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2013
Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysisSoichiro Yoshida, Shinji Tsutsumi, Guillaume Muhlebach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2017
Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular CarcinomaAustin G Duffy, Chi Ma, Susanna V Ulahannan, et al.
Pageof 5